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ABSTRACT
THE ROLE OF CHMP1 IN DROSOPHILA MELANOGASTER
Meagan E. Valentine
Chmp1A has recently been linked to pancreatic cancer, a leading cause of cancer
death in humans. Pancreatic tumors have lowered Chmp1A expression, and it has been
described as a tumor suppressor. Chmp1A is also a member of ESCRT III (Endosomal
Sorting Complex Required for Transport), a conserved protein complex involved in the
degradation and recycling of activated transmembrane receptors. There is a single Chmp1
protein in Drosophila that is homologous to vertebrate Chmp1A; however, Chmp1 hasn’t
been studied in Drosophila. The objective of this study was to characterize Chmp1 in
Drosophila using gene knockdown and over-expression. We used an RNAi fly line to
knockdown Chmp1 in the wing of the fly and created a transgenic fly line to look at overexpression. Our results suggest that Chmp1 may be regulating the Epidermal Growth
Factor pathway and Notch-Delta signaling, as well as the Frizzled-Planar Cell Polarity
pathway.

BACKGROUND

i. ESCRT
Many proteins in the cell membrane, such as ion channels and receptors, are
constantly fluctuating; these proteins can be endocytosed, and then recycled or degraded.
The ESCRT complexes (Endosomal Sorting Complex Required for Transport 0, I, II, III)
play a role in a major pathway used for the targeted degradation of transmembrane
receptor proteins. These complexes are required for control of cell signaling, down
regulation of receptors, as well as other normal and pathological cell processes (1, 2, 3).
In this pathway, activated receptor proteins are usually targeted for degradation by
monoubiquitination. They are then endocytosed and transported to the early endosome
(4). At the early endosome, proteins are sorted into multivesicular bodies (MVBs), which
fuse to the lysosome and are degraded (5, 6). This makes the MVBs very important for
receptor down regulation (7). The MVBs are also important for intercellular
communication and antigen presentation, as they are also able to fuse with the plasma
membrane, expelling their contents into the extracellular matrix (8, 9, 10). This pathway
is highly conserved in eukaryotic organisms.
At least eleven proteins in mammals have been identified as components of
ESCRT-III and are collectively referred to as charged multivesicular proteins (Chmps) (1,
2). All of these Chmps have similar characteristics: they are about 200 amino acids long,
contain a coiled-coil region and charged residues, and they have a basic N-terminus and
an acidic C-terminus (Figure 1) (1, 2).

1

Figure 1. Chmp protein structure.
Chmps are rather small proteins about 200 amino acids in length with a basic N-terminus,
an acidic C-terminus, and a coiled-coil (CC) domain.

ii. Chmp1A
Chmp1A is a highly conserved protein in both complex and simple eukaryotes. In
different organisms it is known by several different names: Chmp1 1 (Chromatin
Modifying Protein1), Chmp1A2 (Charged Multivesicular Protein1), VPS46p/Did2p 3, and
Sal14 (Supernumerary Aleurone Layers 1) (4, 11, 12, 13). In humans, there are two
different isoforms of Chmp1A: a 35 kDa Chmp1A, which localizes to the nucleus, and a
32 kDa Chmp1A, which is located in the cytoplasm (11). The functional and structural
differences between these two Chmp1A species are most likely due to differential posttranslational modification.
It has been shown that the larger and nuclear form of Chmp1A is tightly
associated with the nuclear matrix and has been suggested to play a role in stable gene
silencing within the nucleus (13). In the nucleus, Chmp1A is associated with condensed
chromatin and it has been reported that Chmp1A affects nuclear structure by increasing
nuclear DNA concentration through chromatin condensation (13). Over-expression of

1

Drosophila melanogaster – NP_649051/CG4108
Homo sapiens – NM_002768, this is a variant of Chmp1. There is also a Chmp1B
3
Saccharomyces cerevisiae – NP_012961
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Zea mays - NP_00110521
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Chmp1A affects DNA replication by halting cells in the S-phase of the cell cycle,
possibly by way of its effects on chromatin structure (13). Chmp1A was also found to
physically interact with the Polycomblike (Pcl) protein, and to recruit BMI1 protein, both
of which are members of the Polycomb group (PcG) of transcriptional repressors
responsible for gene silencing during development (13, 14, 15).
The cytoplasmic form of Chmp1A is a member of the ESCRT-III complex.
Chmp1A localizes at the early and late endosomes, where it is involved in protein sorting
and MVB formation (11). The Chmp1A protein has also been shown to bind to the VPS4
protein, which is shown to mediate the ATP-dependant disassociation of the ESCRT
complexes and complete MVB formation (2, 11).
Loss of function of several the ESCRT components has been shown to give rise to
over-proliferative phenotypes that are probably a consequence of failure of protein
sorting. In Drosophila, genetic defects in Vps25 activity cause loss of cell polarity in
epithelial tissue, followed by cell over-proliferation (16, 17). Tsg101, the mammalian
homologue of Vps23 induces cell transformation and tumor formation in mice (2, 18, 19).
Also, HCRP1, the human homologue of Vps37 is associated with hepatocellular
carcinoma (HCC) (20, 21). In addition, mutations in the sal1 gene, the maize homologue
of Chmp1A, cause multiple layers of aleurone cells to form, a phenotype which may
attributed to problematic receptor degradation (12). As a component of ESCRT, Chmp1A
may be important for the control of cell growth by participating in the regulation of
membrane receptor and signaling proteins.

3

iii. Pancreatic Cancer
Chmp1A has been linked to pancreatic cancer in humans (22). Pancreatic cancer
is a leading cause of cancer death, with a five-year survival rate of only four percent. The
mortality associated with pancreatic cancer is due to its aggressive malignancy, its high
resistance to treatment, and that it is often not diagnosed until it is quite advanced (23).
Although much research is in progress, still little is known about its molecular
pathogenesis. However, specific patterns of expression have been identified and
associated with pancreatic adenocarcinomas. Mutations in several genes, including
KRAS, are characteristic of the disease (24). KRAS is a member of the RAS family
oncogenes, of which activating mutations cause over-proliferation and cell survival (24).
KRAS mutations are present in nearly 100% of adenocarcinomas (24).

iv. Drosophila as a Model
In this study, Drosophila melanogaster was used as a model for studying Chmp1
activity. Drosophila is a model organism that is often used for studying the function of
human proteins. This species has a rather short generation time, is easy to work with, has
elegant genetics, and it is inexpensive; all of these characteristics make Drosophila a
good model. Additionally, the Drosophila genome has been sequenced, providing an
important resource to biologists and identifying over 13,000 genes. There has also been
over 100 years of work on Drosophila, which provides researchers with an extensive base
of knowledge of this species (Flybase). There are many sophisticated genetic and
molecular tools that have been developed for studying gene and protein function, many of
which are unique to this organism. However, probably most importantly, there is a great
4

deal of homology between human genes and Drosophila genes. Of about 300 known
human disease genes, almost 200 have homologues in Drosophila (25). We also share
common pathways, making many of the results in Drosophila transferable.
There have been no published studies of Chmp1 function in Drosophila and our
knowledge of vertebrate Chmp1A is incomplete. It is known that there is only one copy
of Chmp1 in Drosophila, which will make it easier to study because we will not have to
worry about the activity of homologous gene products. From previous work in the Collier
lab, it is also known that Chmp1 is expressed in all embryonic tissues. Probably most
importantly, we know that the protein sequence of Drosophila Chmp1 is 49% identical to
Chmp1A in humans, allowing for the conclusions drawn about Drosophila Chmp1
function to be applicable to Chmp1A function in humans.

v. UAS-Gal4 System
The UAS-Gal4 system (Figure 2) is a sophisticated genetic tool that is widely
used in Drosophila studies (26). It was first identified in yeast, but has been modified and
is now used in other systems, including Drosophila and mammalian cell culture. This
system allows for very fine control of the location and the intensity that a gene of interest
will be expressed. When a transgene is under the control of a UAS (Upstream Activating
Sequence) promoter, it will only be expressed in the presence of Gal4. Conveniently,
there are thousands of fly lines that have been designed to express Gal4 in specific areas
of the fly, at different intensities, and sometimes at specific times during development.
This makes controlling gene expression quite easy, as with a single generation cross you
can knock down or over-express a gene where you choose and to the extent you choose.
5

This efficacy of this system is temperature related, with 30 oC producing strongest
expression. There is higher UAS-Gal4 activity in a fly line at 30oC than the same fly line
at 18oC, and therefore a stronger phenotype is exhibited (27).

Tissue-specific promoter in Gal4-expressing flies activates Gal4 expression

Gal4

Expression of gene of interest
UAS

Gene of interest

Figure 2. UAS-Gal4 system in Drosophila

vi. Drosophila Wing Anatomy
The Drosophila wing (Figure 3) is like a flattened balloon. It has a dorsal and a
ventral side that oppose each other, each one cell-layer thick. Cuticular structures called
veins are distributed in a distinctive pattern, contributing rigidity to the wing. The pattern
of these veins is nearly identical between all wild-type wings. The space between veins is
called the intervein tissue. There are four longitudinal veins, L2-L5. These veins cross the
length of the entire wing. There are also two transverse veins, the anterior cross vein and
the posterior cross vein (acv, pcv), which are much shorter and connect the L3 and L4
veins, and the L4 and L5 veins, respectively. Veins L3, L5, and the distal part of L4 are
dorsal wing veins and are located on the dorsal side of the wing (28, 29). The rest are
considered ventral. Two other veins, L1 and L6 exist as well, however they do not extend
into the wing blade (28).
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L1

L2
acv

L6

pcv

L3
L4

L5

Figure 3. Drosophila melanogaster wild-type female wing.
10X, mounted dorsally in GMM.

A wild-type Drosophila wing is a quite regular structure. It is decorated with short
cuticular hairs that generally point distally and are resultant of prehairs, which are
composed of F-actin and microtubules (30). The cells of the developing wing are
polarized within the plane of epithelium, and are packed regularly as hexagons. One wing
prehair is produced at the most distal vertex of each cell (Figure 4) (30).

Figure 4. Wild-type Drosophila wing cells
Each cell is hexagonally shaped with a single wing prehair produced at the distal vertex
of the cell (31).
7

vii. Balancer Chromosomes
There are many advantageous genetic tools available when using Drosophila. One
quite useful and widely used tool is the balancer chromosome. In the fly, these
chromosomes have several characteristics that make doing the genetics easier. Firstly,
and maybe most importantly, these chromosomes contain multiple inversions, which
suppress homologous recombination. If the balancer chromosomes do recombine, the
recombination products may contain duplications or may even lack a centromere.
Because of these mutations, homologous recombination involving balancer chromosomes
produces progeny that are not viable. The balancer chromosomes are also homozygous
lethal, so flies receiving two copies of the balancer do not survive. Additionally, they
have a dominant phenotype, so if a fly carries the balancer chromosome, it can be easily
identified.
There are four chromosomes in Drosophila melanogaster. The first chromosome
is the X, and is used with balancers called First Multiple (FM). Chromosome 4 is not
used with balancers, as no balancer for it exists. The third chromosome balancers are
called Third Multiple (TM) and may contain the dominant marker Stubble (Sb). When a
fly carries this balancer, the bristles on its head and thorax are shortened. The second
chromosome balancer that is often used is Curly of Oster (CyO), and its dominant marker
is Curly (Cy). Flies that carry this balancer have curly wings.
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CHAPTER 1 – CHMP1 AND REGULATION OF GROWTH

Section 1. Introduction

Section 1.1: Overview of Chmp1
Cell proliferation, growth, and migration are regulated by a myriad of different
proteins and pathways, the regulation of which is essential to proper cell behavior. One
small divergence of this tight regulation can cause severe problems in the cell, including
uncontrolled cell growth, or tumors. Tumor suppressors are a set of genes that govern a
variety of normal activities in the cell, ranging from cell cycle checkpoint control to
protein turnover to DNA damage (32). When tumor suppressors are absent or expressed
at low levels, problems such as over-proliferation can occur. In many types of cancers,
tumor suppressor genes have low expression levels or are mutated.
Recent work at the Marshall University School of Medicine has shown that
Chmp1A regulates proliferation in zebrafish and in mammalian cell culture. Both the
over-expression and knockdown of Chmp1A in zebrafish embryos causes hyperplasia
formation, suggesting that Chmp1A is involved in the regulation of growth (33). When
looking at HEK 293 (Human Embryonic Kidney) cultured cells, Chmp1A overexpression significantly inhibits growth by arresting cells in S-Phase (13), while Chmp1A
knockdown promotes growth (33). Additionally, HEK 293 cells with reduced Chmp1A
activity form tumors when injected into nude mice, while control HEK 293 cells do not
(33).
Chmp1A has been linked to pancreatic cancer in humans, as pancreatic tumors
show a considerable reduction of Chmp1A activity (33). A recent study shows that
9

knockdown of Chmp1A in a pancreatic tumor cell line (PanC-1) promoted growth, while
over-expression inhibited growth, and was also associated with an increase of p53, an
extremely important tumor suppressor (22). These results provide evidence that Chmp1A
functions in the regulation of growth, since when it is lost growth control is abnormal.
This suggests that Chmp1 may function as a tumor suppressor, at least in the human
pancreas (22).
To date, there are no published Chmp1 (homologue of human Chmp1A) function
studies in Drosophila. As this is the first study on Chmp1 function, we began at a
classical starting point by simply looking at Chmp1 knockdown and over-expression.
Chmp1 was knocked down and over-expressed in the Drosophila wing. Chmp1
knockdown resulted in oversized wing veins that looked as if they had overgrown. The
phenotype obtained in the Chmp1 knockdown wings is very similar to phenotypes
obtained in wings with over-active EGF, suggesting a possible role for Chmp1 in
regulating EGF activity. When Chmp1 was over-expressed in the Drosophila wing, the
phenotypes obtained were similar to reduction of Delta (34), a protein involved in Notch
signaling. This suggests a possible role for Chmp1 in the regulation of Notch signaling as
well. As altering Chmp1 activity produces phenotypes which are suggestive of Notch and
EGF regulation, it is appropriate to overview these pathways.

Section 1.2: Epidermal Growth Factor Pathway (Figure 5)
In humans, EGF signaling plays an important role in the regulation of cell growth,
migration, differentiation, and proliferation (35). In Drosophila, proper EGF signaling is
crucial in many developmental processes including oogenesis (36), eye development (37,
10

38), growth of imaginal discs (39), and wing vein development (40, 41). The EGF
receptor is a transmembrane protein, which functions a receptor tyrosine kinase. Binding
of the EGF receptor activates the Ras signaling pathway, which ultimately results in
altered gene expression (42, 43). The EGF pathway is regulated by a several feedback
mechanisms. Many different inhibiting and activating molecules regulate the EGF
receptor pathway, which are often induced by EGF receptor activity (44).
The three known negative regulators of EGF signaling in Drosophila are Argos
(Aos), Sprouty (Sty), and Kekkon-1 (Kek-1). Aos is a secreted molecule specific for the
EGF receptor. It blocks ligand binding and can affect many surrounding cells (44, 45).
Sty is an intracellular inhibitor, which inhibits Ras signaling, thereby inhibiting EGF
signaling (46). Kek-1 is a transmembrane protein that interacts directly with the EGF
receptor to inhibit ligand binding (47, 48).
There are several different activating ligands of EGF receptor: Spitz, Gurken,
Vein, and Keren. Gurken is expressed only in the oocyte and is important for oogenesis
(49). Vein (Ve) is a secreted factor that binds and activates the EGF receptor (50). Keren
is a transmembrane protein that must be cleaved in order to become active (51). Lastly,
Spitz is the major EGF ligand, which, like Keren, is a transmembrane protein that is
inactive until cleaved (52). The transmembrane protein called Rhomboid (Rho), also
known as Veinlet (Vn), is not a ligand of the EGF receptor; however it is an important
activator of EGF in that both Spitz and Keren are present, but do not become active until
cleaved by Rho (53, 54).
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Figure 5. Regulators of the Drosophila EGF receptor (EGFR).
The three known inhibitors (red) are Spry, Kek-1 and Aos. The two known activators
(green) are Ve and Rho (Vn) (107).

Section 1.3: Notch-Delta Signaling
Notch-Delta signaling is conserved in animals and has multiple essential activities
during development such as lateral inhibition, boundary formation and cell fate decisions
(55). Notch is a single pass transmembrane receptor protein, which was originally
identified in Drosophila (56). In Drosophila, there is only one Notch protein, and it is
expressed as a heterodimer 5 at the membrane (57, 58). It has an ectodomain called the
Notch Extracellular Domain (NECD), which is involved in binding interactions, a Notch
Intracellular Domain (NICD) critical for protein-protein interactions and transcriptional
activation (59, 60, 61). Notch responds to two ligands, Delta and Serrate, which are also
membrane-bound proteins (62, 63, 64). Ligand binding of the NECD leads to cleavage of
5

The Notch protein forms a homodimer at the membrane. However, for Notch to be
active, one of the units is cleaved, leaving a heterodimer at the membrane (58).
12

the NICD, which translocates to the nucleus where it interacts with Suppressor of
Hairless [Su(H)], a DNA-binding protein, and regulates the transcription of its target
genes (65, 66). As both the ligands and receptors in Notch-Delta signaling are
transmembrane proteins, signaling is short range.
As wings go, Notch and EGF signaling work together to promote correct wing
vein formation (Figure 6). Delta is expressed in the center of wing vein territory while
Notch is expressed in cells bordering the veins (34). Delta expression activates Notch,
which activates Su(H) (65). Su(H) then activates expression of a gene called Enhancer of
split [E(spl)mβ] (67). E(spl)mβ then goes on to repress rho transcription (68), confining
rho expression to the vein, where it activates EGF signaling (40).

Figure 6. Notch and EGF signaling regulate vein size in the Drosophila wing.
The blue areas represent the borders of intervein, while the orange represents vein tissue.
Expression of Rhomboid activates the Der receptor (EGF receptor), which activates
expression of the Notch ligand, Delta. Delta then activates Notch in the adjacent cell,
which causes E(spl)mβ to repress Rhomboid expression, restricting Rhomboid, and thus
EGF signaling, to the vein (28).
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Section 2. Objective and Hypothesis
Section 2.1: Objective
The objective of this study was to characterize the function of Chmp1 in
Drosophila by observing the effects of knockdown and over-expression. Chmp1
knockdown was achieved using RNAi, and over-expression was achieved by creating a
transgenic fly line.

Section 2.2: Hypothesis
We hypothesize that Chmp1 in Drosophila will function in the same
developmental processes as Chmp1A in vertebrates.

Section 3. Materials and Methods
Section 3.1: Gels
All gels were 0.8% agarose gels containing ethidium bromide. In a 50mL
Erlenmeyer flask, 0.4g of agar was added to 50mL of 1X TBE (Tris-Borate-EDTA)
buffer from a 10X stock solution. The mixture was heated in a microwave for about 35
seconds, until the agar had dissolved. One uL of ethidium bromide was added to the
mixture, and it was swirled until well mixed. The gel was poured and allowed to cool.
All gels were run at 120 volts for approximately 90 minutes alongside 1KB DNA ladder.
They were run in 1X TBE buffer, and analyzed on a GelDoc (Biorad, Hercules, CA,
USA).
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Section 3.2: Transformation of E. coli cells
The competent cells were thawed on ice, and 50uL was added to a 1.5mL
microcentrifuge tube. 0.85uL of -mercaptoethnol was added to the cells, and then they
were incubated on ice for 10 minutes, swirling every 2 minutes. 10uL of DNA was added
to the cells, and they were incubated on ice for 30 minutes. In the meantime, 100uL of
LB Broth was heated in a 42oC water bath. At the end of the incubation period, the cell
tube was heat pulsed in a 42oC water bath for 45 seconds, and then placed on ice for 2
minutes. The cells were then added to the broth tube and incubated at 37oC for 30
minutes. The transformed cells were plated (~75uL/plate) onto LB agar plate containing
chloramphenicol (final concentration: 2uL/mL) or ampicillin (stock concentration:
50ug/mL, final concentration: 1uL/mL), depending on the vector’s resistance, and grown
overnight at 37oC. The next day, individual colonies were selected6 and cultured in
200mL of LB broth containing their specific antibiotic, and shaken overnight at 150rpm
at 37oC. The DNA was then purified using a Qiagen HiSpeed Plasmid Midi Kit
(Valencia, CA, USA), following the manufacturer’s procedures. The DNA was separated
on a gel and analyzed.

Section 3.3: Plasmid preparations
All large plasmid preparations were made using 200mL of LB broth and either
2ul/mL of chloramphenicol or 1uL/mL of ampicillin, depending on the vector’s

6

The pBluescript vector allowed for blue/white color selection. When using this vector,
the plates were covered with a mixture of IPTG (72ug/mL) and X-Gal (40ug/mL) before
plating. The white colonies that grew represented transformed cells, while blue colonies
represented non-transformed cells.
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resistance. They were shaken overnight at 37oC and purified using the Qiagen HiSpeed
Plasmid Midi Kit (Valencia, CA, USA).
All small plasmid preparations were made using 3mL of LB broth and either
ampicillin or chloramphenicol. They were shaken overnight at 37 oC and purified using
the Qiagen QIAprep Spin Miniprep Kit (Valencia, CA, USA).

Section 3.4: Digests
All digests were 100uL solutions in a 1.5mL microentrifuge tube. Digests were
always performed in sets of two so they could be combined and used in a
phenolchloroform extraction. The digests consisted of 10uL of DNA (~5ug) solution,
10uL of buffer, 70uL of water and 10uL of enzymes (Table 3). The digests were
incubated at 37oC for 1 hour, then run on a gel and analyzed.

Section 3.5: Phenolchloroform extraction
In a 1.5mL microcentrifuge tube, 200uL of phenol chloroform was added to
200uL7 of DNA solution and vortexed for 10 seconds, and then centrifuged for 4 minutes
at maximum speed. The top layer (~200uL) was removed and transferred into a new
microcentrifuge tube. Then 20uL of 3M pH5.2 sodium acetate was added and mixed by
vortexing. 400uL of isopropanol8 was added and mixed by vortexing. The sample was
incubated for 30 minutes on ice, and then centrifuged at maximum speed for 8 minutes to
pellet the DNA. The supernatant was discarded and the pellet was washed with 70%

7

For digests and PCR products, combine two vials (100uL each) to make a 200uL
sample of DNA solution.
8
When purifying cDNA, 100% ice cold ethanol was used.
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ethanol and microcentrifuged again. The supernatant was again discarded, and the pellet
was air dried overnight. The next day, 20uL of buffer EB from Qiagen’s QIAprep Spin
Miniprep Kit (Valencia, CA, USA) was added to resuspend the pelleted DNA. The DNA
solution was then run on a gel and analyzed.

Section 3.6: Chmp1 insertion into pUAST and pUASHM
Chmp1 cDNA was digested out of the pBluescript vector in 8 - 100uL digests of
each construct containing 40uL (~20ug) of DNA solution, 10uL of their respective
enzymes (Table 3), and 10uL of their respective buffer and 40uL of water. Then 4 –
200uL phenol chloroform extractions of each construct. The samples of each construct
were loaded on gel. Eight wells were used, and each well contained 10uL of sample and
2uL of 10X loading dye, and were run alongside a 1kb DNA ladder for about 90 minutes
in 1X TBE buffer

Section 3.7: Ligation
All ligations were 10uL of solution prepared in a 1.5mL microcentrifuge tube.
They consisted of 1uL of T4 DNA ligase, 1uL ligase buffer, 3uL of vector (~1ug/uL),
4uL of cDNA (~1ug/uL) and 1uL of water. They were incubated at 4 oC overnight.

Section 3.8: Fly food preparation
In a large pot over a burner, 1000mL of distilled water was mixed with 18 grams
of agar. The mixture was heated and stirred. In the meantime, 500mL of water was added
to 30 grams of Brewer’s yeast, along with 120 grams of cornmeal in a 1000mL beaker.
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Once the water/agar mixture began to boil, 225mL of molasses was added while stirring,
followed by the cornmeal/yeast mixture. While stirring frequently, the mixture was
brought to a boil. It was cooled with lid on for 10 minutes, and cooled with the lid off,
stirring occasionally, for 30 minutes (vials) to an hour (bottles). After the cooling period,
13.2mL of propionic acid and 42.75mL of hydrobenzoic acid were added. The mixture
was stirred and poured into either bottles or vials. The bottles/vials were stored overnight
at 18oC to completely cool and plugged the next day with cotton.

Table 1. Primers used for PCR
Restriction enzyme sites in bold. GGATCC: BamH1, CATATG: Nde1, CTCGAG: Xho1,
GAATCC: EcoR1
Name

Sequence

pUASHM forward

GGGCCCGGATCCACGTCGCATATGTCTACGAGTT
CCATGG

pUASHM reverse

TACCACCTCGAGTTATTCAGCCTGGCGGAGACG

pUAST forward

ACGTCGGAATCCATGTCTACGGAGTTCCATGG

pUAST reverse

TACCACCTCGAGTTATTCAGCCTGGCGGAGACG

Table 2. Primers used for sequencing
Name

Sequence

pUAST, pUASHM forward

TGCAACTACTGAAATCTGC

pUAST, UASHM reverse

CCAATTATGTCACACCACAG
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Table 3. Enzymes used.
The enzymes next to the number one were used with the first construct (Chmp1 insertion
into pUASHM) and enzymes next to the number two were used with the second construct
(Chmp1 insertion into pUAST).
Vector

Enzymes

Digest of Chmp1 PCR product

1. BamH1 and Xho1
2. EcoR1 and Xho1

Digest of pBluescript

1. BamH1 and Xho1
2. EcoR1 and Xho1

Digesting Chmp1 out of pBluescript

1. Nde1 and Xho1
2. EcoR1 and Xho1

Digest of pUASHM

1. Nde1 and Xho1

Digest of pUAST

2. EcoR1 and Xho1

Table 4. Genotypes of flies used
Name

Genotype

Oregon R (wild-type)

Oregon R-C

Chmp1IR (VDRC)

w1118; P{GD11219}v21788/CyO

Chmp1IR (TriP)

y1 v1; P{TRiP.HM05117}attP2

MS1096-Gal4

w1118 P{w+mW.hs=GawB}BxMS1096

argos7

argosDelta7/TM3, Sb1

argosw11

w8; P{w+mW.hs=lwB}argosW11/TM3, Sb1

UAS-argos on 1 &2

y1,w*P{w+mC=UASargos.M}301021;P{w+mC=
UAS argos.M}30-85-1

sty5

w*; styDelta5/TM3, Sb1 P{w+mC=35UZ}2

argosr/t

argosr/t

kek-1

y1 wp67c23; P{y+t7.7 w+mC=wHy}kek1DG23812

ve vn

rhove-1, vn1
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Section 4: Results
To date, there are no published studies on Chmp1 function in Drosophila.
Classically, protein and gene studies begin with over-expression and knockdown.
Because no one has studied Chmp1, no classical mutant exists. So in order to obtain
Chmp1 knockdown, a transgenic RNAi fly line was obtained from the Vienna Drosophila
Resource Center (69). This fly line will allow for control of Chmp1 knockdown, because
the Chmp1 RNAi transgene is downstream of a Gal-4 responsive UAS promoter. In order
to look at Chmp1 over-expression, transgenic fly lines had to be created. Two expression
vectors were used: pUAST and pUASHM, both of which mediate random insertion of the
transgene into the Drosophila genome. Each of these vectors allowed for Chmp1
transgene insertion downstream of a Gal4-responsive UAS promoter, which permits fine
control of Chmp1 over-expression once in the fly. The pUASHM vector will tag the
Chmp1 protein with an N-terminal HisMyc (HM) tag that will allow for visualization and
localization studies in the fly.

Section 4.1: Chmp1 knockdown
Chmp1 function has not been studied in the Drosophila system. A classical
Drosophila Chmp1 mutant does not exist, so to study Chmp1 knockdown, RNAi was
used. A Chmp1 RNAi line was obtained from Vienna Drosophila RNAi Collection
(VDRC) (69). The Chmp1 RNAi (Chmp1IR) fly line obtained expresses Chmp1 hairpin
loop RNA (hpRNA), which is complementary to Chmp1 mRNA. The hpRNA is
expressed under a Gal4 responsive UAS promoter, which allows for very fine control
over Chmp1 knockdown. Expression of Chmp1 hpRNA initiates the RNAi pathway and
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mediates the destruction of Chmp1 mRNA, knocking down Chmp1 expression (Figure 7).
The Chmp1 hpRNA is located on the second chromosome of the fly, and is balanced with
CyO.

Hairpin RNAs
(complementary to Chmp1
mRNA)
Cleavage of hpRNA
by DICER
Unwinding by RISC

Cleavage of Chmp1 mRNA

Chmp1 mRNA destruction

Figure 7. Mechanism of Chmp1 RNAi in flies.
The hpRNA expressed is double stranded RNA, which is recognized by the cell. An
enzyme called DICER is recruited to the site and cleaves the hpRNA into 20-22
nucleotide pieces called small interfering RNAs (siRNA). Then a complex called RNAInduced Silencing Complex (RISC) unwinds the double stranded siRNAs. When this
complex comes into contact with Chmp1 mRNA, the siRNA binds, and RISC cleaves the
mRNA. The mRNA is then destroyed and recycled in the cell.

Section 4.2 (A-E): Generation of Transgenic Flies (Figures 18 and 19)
As Chmp1 has not been studied in Drosophila, there was no available fly line that
would allow for Chmp1 over-expression. Thus, transgenic UAS-Chmp1 fly lines were
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created. This was accomplished by inserting the Chmp1 coding sequence into a vector
downstream of a UAS promoter. The vectors that contain the UAS promoter and allow
for Chmp1 insertion are called pUAST and pUASHM. pUASHM adds a HM tag to the
Chmp1 protein.

Section 4.2 A: cDNA preparation
Four different vectors were used: GH26351 (pOT2 vector (Figure 20)) containing
Chmp1 cDNA,) has chloramphenicol resistance, pUAST (Figure 21), pUASHM (Figure
22) and pBluescript (Figure 23) all have ampicillin resistance. The GH26351 plasmid
was received from Drosophila Genomics Resource Center (DGRC). Preparations of the
plasmids were made using XL-1 Blue Competent Cells (Stratagene, La Jolla, CA, USA),
which were separately transformed by each vector. To check that the vectors were
correct, they were digested and analyzed on a gel.
To prepare the vectors (pBluescript, pUAST, pUASHM) for Chmp1 insertion,
they were digested with the appropriate enzymes (Table 3). The vectors were then
purified and concentrated using a phenolchloroform extraction. During the
phenolchloroform extraction, isopropanol was used, removing the linker DNA that was
digested out of the vector to prevent re-insertion. The DNA was then run and analyzed on
a gel. At this point, the vectors were ready for Chmp1 insertion.
Now that the vectors were ready for Chmp1 insertion, a Chmp1 cDNA needed to
be prepared from GH26351. The Chmp1 cDNA was amplified from the vector using the
PCR Extender System Kit (5 Prime Inc, Maryland, USA) and a Biometra Tgradient
Thermoblock (Biometra Biomedizinische Analytik GmbH, Rudolf-Wissell, Goettingen,
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Germany). Two sets of primers (Invitrogen, Carlsbad, CA, USA) were used to amplify
Chmp1 from the pOT2 vector (Table 1). The set of primers for the first construct were
pUASHM forward, which added restrictions cut sites for BamH1 and an Nde1, and
pUASHM reverse, which added the restriction cut site for Xho1, to allow for insertion
into the pBluescript and the pUASHM vectors. The set of primers for the second
construct were: pUAST forward, which added a restriction cut site for EcoR1, and
pUAST reverse, which added the restriction cut site for Xho1, to allow for insertion into
the pBluescript and the pUAST vectors. The cycling parameter for amplifying PCR
products was 30 cycles of 94 oC for 30 seconds, 55o for 30 seconds and 72 oC for 2
minutes. Eight individual but identical PCR vials were run. DNA from PCR was run and
analyzed on a gel.

Section 4.2 B: Preparing Chmp1 for insertion into pBluescript
As the pUAST and pUASHM vectors are quite large and less ready to be taken up
during a transformation, the PCR-amplified Chmp1 cDNA was first inserted into the
much smaller pBluescript vector. The cDNA from PCR was purified and concentrated
by a phenol-chloroform extraction. The concentrated DNA was then digested with
enzymes respective to which vector it would be inserted. The DNA of the first PCR
product9 was digested with BamH1 and Xho1, while the DNA of the second PCR
product10 was digested with EcoR1 and Xho1. The DNA was then purified and
concentrated using a phenol-chloroform extraction. Chmp1 was now ready for insertion
into pBluescript.
9

Product of PCR performed with pUASHM primers
Product of PCR performed with pUAST primers
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10

Section 4.2 C: Chmp1 in pBluescript
The precipitated pBluescript vector and each Chmp1 preparation were combined
in a ligation. XL-1 Blue Competent Cells were transformed. The pBluescript vector
allowed for blue/white color selection. When using this vector, the plates were covered
with a mixture of IPTG (72ug/mL) and X-Gal (40ug/mL) before plating. The white
colonies that grow represent transformed cells, while blue colonies represent nontransformed cells. So the next day, individual white colonies were selected and made into
small preparations and grown overnight. The plasmid was then purified using the Qiagen
QIAprep Spin Miniprep Kit (Valencia, CA, USA). To check that the transformation was
successful and that the plasmids were correct, the DNA was digested with enzymes that
should release the insert, and run on a gel and analyzed. Large preparations of DNA were
made with the samples that appeared to have the correct vector and insert size, and then
sequenced, to ensure that the Chmp1 sequence was correct, by the Genomics Core
Facility of Marshall University’s Joan C. Edwards School of Medicine, using the M13
forward and reverse primers.

Section 4.2 D: Preparing Chmp1 for insertion into pUAST and pUASHM
When the correct Chmp1 sequence was obtained, it was then removed from the
pBluescript vector, and inserted into the pUAST and pUASHM vectors. Very high cDNA
concentrations were required for this section of the protocol because the last step was a
gel extraction, which was not extremely efficient in recovering DNA. The Chmp1cDNA
was digested out of the pBluescript vector. A large amount of plasmid DNA was digested
in order to maximize the amount of digested Chmp1 cDNA. To concentrate the cDNA,
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the digests were precipitated in a phenol-chloroform extraction. The samples of each
construct were loaded and run on gel. The gels were then analyzed under UV light and
the inserts were cut out and collected using the QIAquick Gel Extraction Kit (Qiagen,
Valencia, CA, USA). The DNA solution obtained from the gel extraction was run on a
gel to ensure that the procedure was successful. When a high concentration of Chmp1
was obtained, it was then ready to be inserted into the pUAST and pUASHM vectors.

Section 4.2 E: Chmp1 in pUAST and pUASHM
Now that Chmp1 was ready for insertion into pUAST and pUASHM, the cDNA
could now be ligated into the vectors. Two ligations were performed, one for each
construct. XL1-Blue Ultra Competent Cells (Stratagene, La Jolla, CA, USA) were
transformed separately by each ligation. The next day, individual colonies were selected
made into small preparations, and grown overnight. The plasmid was then purified using
Qiagen’s QIAprep Spin Miniprep Kit (Valencia, CA, USA), and digested to check for the
correct vector and insert size. The samples that appeared to be correct were made into
larger preparations and purified with the HiSpeed Plasmid Midi Kit ( Qiagen, Valencia,
CA, USA). The plasmids were then sequenced by the Marshall University Genomics Core

Facility with custom primers (Invitrogen, Carlsbad, CA, USA). The same primers were
used for both pUAST and pUASHM sequencing (Table 2).
When the correct sequence was obtained, the samples were then prepared for
insertion into the Drosophila genome. A commercial generator of transgenic flies called
BestGene Inc. (Chino Hills, CA, USA) was used. They required at least 50uL of DNA
with a concentration of 1ug/uL. The concentrations of pUAST and pUASHM vectors
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containing the correct Chmp1 sequence were measured using a ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). A concentration of
1ug/uL was needed, but was not obtained. The Qiagen HiSpeed Plasmid Midi Kit
produces about 1mL of purified plasmid in solution; so, to obtain a higher concentration,
400uL of each plasmid solution was concentrated by a phenolchloroform extraction and
resuspended in 50uL of water. The concentrations were measured again using a ND-1000
spectrophotometer, and each had reached a concentration of 1ug/uL or higher. The
plasmids were then sent to BestGene Inc. (California, USA).
BestGene Inc. provided the service of integrating the Chmp1 transgene into the
Drosophila genome. Both the pUAST and pUASHM vectors have P elements, which are
transposons that are often used in Drosophila to create genetically modified flies. These P
elements function to insert the Chmp1 transgene and a white gene together into the
genome of the fly (Figure 8). This process is random, and therefore gives rise to the
possibility of insertion within a gene, or multiple insertions. The white gene, which gives
the eye of the fly a red color, serves as a marker so that only flies with the white+
phenotype have the Chmp1 transgene.
The Chmp1 constructs that were created, along with a helper plasmid, were
injected near/into the germ cells of white- (white eye) embryos. The helper plasmid
encodes a transposase, which is required to insert the transgene into the genome. Some of
the germ cells take up the plasmids, and the Chmp1 transgene and the white gene get
inserted into the genome of those cells. When the injected white- embryo develops into an
adult fly, it can be crossed to another white- fly. The successful BestGene lines had the
Chmp1 transgene, which was evident by its white+ phenotype.
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Figure 8. P-elements and transgenes.
Both the pUAST and the pUASHM use P elements to insert the Chmp1 transgene into the
genome of the fly. The P elements also insert the white gene, which functions as a
indicator that a fly has the Chmp1 transgene.

Twenty separate and successful fly lines (ten for each vector preparation) were
returned from BestGene Inc. In order for these fly lines to be very useful, it will be
necessary to determine the chromosome of Chmp1 insertion. The lines will also have to
be balanced to ensure that the stock remains stable.

Section 4.3 (A & B): Over-expression and knockdown of Chmp1 in the wing
When beginning a study on protein function, the usual place to begin is to observe the
results of loss of function, or losing protein activity, as well as gain of function, or overexpression of that protein. The results and phenotypes of these first two studies can give
insight to the protein’s function. Drosophila is a very well studied model organism. So, if
mis-expression of a protein interrupts a signaling pathway, the phenotypes observed may
give a clear indication as to which pathways that protein is involved.

Section 4.4 A: Knockdown of Chmp1 in the wing
Now the tools were available to both over-express and knock down Chmp1 in the
fly. Achieving Chmp1 knockdown was very simple; using the RNAi fly line, it only
required a single generation cross. In the RNAi line, the Chmp1IR transgene is under the
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control of a UAS promoter, meaning Chmp1 hpRNA is only expressed in the presence of
the Gal4 protein. A single generation cross between Chmp1IR virgin females and males
that express Gal4 in the wing will result in offspring with Chmp1 knockdown in the wing
(Figure 9).

x
Fly expressing
Gal4 in wing

Chmp1IR fly

Fly with Chmp1 knockdown
in wing

Figure 9. Drosophila single generation cross to achieve Chmp1 knockdown

The Gal4 line that was used is called MS1096-Gal4. MS1096-Gal4 only drives
Gal4 expression in certain parts of the fly, most strongly on the dorsal side of the
developing wing. Three separate crosses were set up, each with ten virgin Chmp1IR/Cy
females to ten MS1096-Gal4/Y; Cy/Sco males. One cross was kept at 25oC, one at 28oC,
and one at 30oC. The parent generation was moved to a new vial with fresh fly food every
two to three days. When the first generation of these crosses was fully developed, the
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right wing of MS1096-Gal4/X; Chmp1RNAi/Sco female flies was dissected off, and
mounted dorsally onto a microscope slide in GMM (70). It should be mentioned that for
all of the crosses completed in these studies, the first generation was quite large (>100
flies). For every cross that was performed, at least 50 flies were analyzed and at least 10
wings were mounted. The results presented for each cross were consistent and
representative of the relative first generations.
When Chmp1 was knocked down in the wing of the flies, the result was
overgrowth of dorsal wing veins L3 and L5 (Figure 10B). Overgrowth of wing veins is a
phenotype that is often associated with over-active EGF signaling. The results from this
initial Chmp1 knockdown suggest that Chmp1 may be involved in regulation of growth
in Drosophila, as it seems to be so in zebrafish and mammalian cell culture. More
specifically, it seems that Chmp1 may be involved in regulating EGF signaling. As
knockdown of Chmp1 results in phenotypes similar to over-active EGF, Chmp1 may
negatively regulate the EGF pathway.
In order to investigate this possibility further, Chmp1 was knocked down in the
wing, while at the same time reducing activity of the positive and negative regulators of
the EGF pathway. Some only slightly more complicated crosses were performed to check
for Chmp1 involvement in EGF signaling. MS1096-Gal4/X; Cy/Sco virgin females were
again crossed to Chmp1IR males. From that cross, first generation males that were
MS1096-Gal4/Y; Chmp1IR/Sco were collected and used for six separate crosses. They
were crossed to vevn, kek-1, aosΔ7, aosw11 and styΔ5 virgin females11. All of these

11

In Drosophila, fly lines are often named for their mutation. So an Argos fly is deficient
in Argos protein, or an Argos mutant. All of the EGF mutants used in this study were
heterozygous mutants, with the exception of vevn.
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mutations are heterozygous, and therefore only reduce the activity of the protein/gene for
which they are specific. Three vials of each cross were prepared with one kept at 25 oC,
one at 28oC, and one at 30oC. When the flies from these crosses were fully developed, the
right wing of MS1096-Gal4; Chmp1IR; heterozygous EGF mutant female flies was
dissected off and mounted dorsally on a microscope slide in GMM.
EGF signaling is very important for the formation of wing veins. When EGF is
over-active, the result is over-sized wing veins. On the contrary, when EGF is reduced,
wing veins are reduced in size or even missing. Wings lacking both ve and vn (rho)
(activators of EGF) have no veins (71), because when the activators of EGF are missing,
the only regulators of EGF present are repressors, and thus EGF signaling is significantly
repressed. However, Drosophila wings heterozygous for vein and rho (ve) alleles are wild
type, suggesting that reduced activity of vein and rho is sufficient to achieve proper EGF
signaling. Chmp1 knockdown in the wing results in overgrowth wing veins, suggesting
that EGF becomes over-active in the absence of Chmp1 (Figure 10).
So what happens when Chmp1 is knocked down at the same time as reducing Ve
and Vn? When Chmp1 was knocked down in the wing in heterozygous for alleles of the
activators of the EGF pathway, rho (ve) and vein, the result was a normal sized wing vein
(Figure 10C). This is very interesting, as it seems that the Chmp1IR phenotype requires
EGF activators because without them, the Chmp1IR phenotype is extinguished and the
wing appears to be wild-type. This suggests that Chmp1IR phenotype is dependent upon
the EGF pathway and that Chmp1 may be regulating EGF signaling.
Chmp1 was also knocked down in the wing in combination with reduced activity
(heterozygous mutants) of each of the negative regulators of EGF (kek-1, styΔ5, and aosΔ7)
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separately (Figure 10 D-F). The result was wing veins that were much larger than those
acquired by sole Chmp1 knockdown. Knocking down Chmp1 and reducing just one of
the EGF negative regulators greatly enhances the Chmp1IR phenotype. However, wings
that were heterozygous for kek-1, styΔ7, or aosΔ7 separately appeared to be wild type. This
result also suggests that the Chmp1IR phenotype is dependent on the EGF pathway and
offers more evidence that Chmp1 is specifically important for proper EGF signaling, and
thus wing vein development.
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Figure 10. Chmp1 knockdown in the wing.
All wings were developed at 28oC. A. Oregon R : a wild-type wing with normally sized
wing veins. B. MS1096-Gal4; UAS-Chmp1IR: Chmp1 knockdown in the wing results in
wider wing veins. C. MS1096-Gal4; UAS-Chmp1IR; rhove-1, vn1/+: Chmp1 knockdown,
along with reduced activity of EGF positive regulators rho and vein results in wild-type
sized wing veins. D. MS1096-Gal4; UAS-Chmp1IR; argos7/+: Knockdown of Chmp1
along with reduced activity aos, a negative regulator of EGF, results in veins much wider
than those observed with sole Chmp1 knockdown. E. MS1096-Gal4; UAS-Chmp1IR;
sty5/+: Knockdown of Chmp1 along with reduced activity of sty, a negative regulator of
EGF, results in much wider veins. F. MS1096-Gal4; UAS-Chmp1IR; kek1/+:
Knockdown of Chmp1 along with reduced activity of kek-1, a negative regulator of EGF,
also results in much wider veins.

RNAi fly lines express hpRNA, specific to a gene of interest, under the control of
a Gal4 responsive UAS promoter. The creation of an RNAi line is not a foolproof
process, and there are several problems of which to be aware. For example, when the
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transgene coding hpRNA is inserted into the genome of the fly, the insertion is
completely random. This could be problematic, as insertion within or near a gene could
affect or even disrupt that gene’s expression. Additionally, when the hpRNA is
expressed, it is supposed to cause destruction of the mRNA for which it is specific.
However, there is the possibility that the hpRNA does not target the mRNA well, or that
it could target a different mRNA in addition to Chmp1 mRNA. Therefore, it is important
to assess whether the phenotypes we observe are actually due to Chmp1 knockdown,
rather than a result of the transgene’s position within the genome of the fly, or a
malfunction of the hpRNA. There is another Chmp1 RNAi fly line available from
Harvard Medical School’s Transgenic RNAi Project (TRiP) (72). This Chmp1 RNAi line
is different from the VDRC line in that the hpRNA is on a different chromosome, and it
targets a different portion of the Chmp1 mRNA (Flybase). Therefore, observing similar
phenotypes from both the TRiP Chmp1IR line and the VDRC Chmp1IR fly line would be
good evidence that the phenotypes previously obtained were in fact due to Chmp1
knockdown.
In order to test this, TRiP Chmp1IR female virgin flies were crossed to MS1096Gal4 males. The adult flies were moved to a vial of fresh food every 2-3 days and the
developing first generation was incubated at 25oC, 28oC and 30oC. The right wing of the
first generation adult female flies were dissected off and mounted dorsally on a
microscope slide in GMM. Chmp1 was knocked down using the TRiP flies resulted in
wing vein overgrowth, a phenotype very similar to that obtained from Chmp1 knockdown
using the VDRC fly line (Figure 11). This offers evidence that the Chmp1 knockdown
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and interaction phenotypes obtained previously were in fact due to Chmp1 knockdown,
rather than off-target effects.

Figure 11. TRiP Chmp1 knockdown in the wing at 28oC

Section 4.3 B: Over-expression of Chmp1 in the wing
When beginning a study on protein/gene function, the classical place to begin is
knockdown and over-expression. We were able to look at knockdown rather easily using
an RNAi line. As we have only recently acquired the resources available to study overexpression, Chmp1 over-expression has only been very briefly investigated.
The transgenic fly lines that were created are designed to work using the UASGal4 system. Chmp1, located downstream of a Gal-4 responsive UAS promoter, was
inserted into the genome of the fly. Therefore, a simple cross of a UAS-Chmp1 fly line to
a Gal4 driver fly line should be sufficient to achieve Chmp1 over-expression. As
mentioned before, twenty different fly lines were created. Ten of the fly lines express a
Chmp1 protein tagged with HM, and the other ten are untagged. It is important to know
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the phenotypes of most, if not all lines for several different reasons. Firstly, the Chmp1
cDNA was inserted randomly into the genome. This means it could have been inserted
within or near genes whose mis-expression could lead to false Chmp1 phenotypes. Also,
as one of the Chmp1 lines is tagged, it is possible that a tag could affect Chmp1 protein
activity, thereby resulting in a false phenotype. If Chmp1 is over-expressed in many of
the fly lines and similar phenotypes are obtained from all of them, the phenotype
observed is most likely a result of Chmp1 over-expression. It is likely that the phenotypes
will be slightly different, depending on the location of the Chmp1 transgene insertion. If
Chmp1 was inserted into a highly expressed part of the genome, stronger phenotypes
should be obtained. On the other hand, if Chmp1 was inserted into a weakly expressed
portion of the genome, expression will be hindered and weak phenotypes will result.
UAS-Chmp1 male flies were crossed to MS1096-Gal4 virgin females. The parent
generation was transferred to a new vial of fly food every 2-3 days. The developing first
generation flies were incubated at 25oC, 28oC and 30oC. When the flies were fully
developed, the right wings of males and females were dissected off and mounted dorsally
onto a microscope slide in GMM.
To date, nineteen of the twenty lines have been investigated, and all of the
phenotypes obtained have been very similar. The last line did not survive and therefore
could not be investigated. Chmp1 over-expression in the wing of the fly results in: 1.)
occasional loss of the anterior cross vein (acv) and/or posterior cross vein (pcv); and, 2.)
phenotypes indicative of problematic Notch-Delta signaling, specifically, reduction of
Delta (M-89). The phenotypes obtained from both tagged (Figure 14) and untagged
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(Figure 13) UAS-Chmp1 lines are similar, suggesting that the phenotype is real, and that
the activity of the epitope-tagged Chmp1 protein is not altered by the HM tag.
The vein phenotypes observed are quite similar to phenotypes observed when the
fly wing has decreased activity for Notch signaling ligand, Delta (Figure 12). Since
altering Chmp1 activity produces a phenotype related to faulty Notch signaling, Chmp1
may be involved in regulating the Notch pathway. These results are very recent, and
further investigation into the involvement of Chmp1 with the Notch pathway is needed.

Figure 12. Loss of Delta in Drosophila wing
Adult wing phenotype of DlPlacZ/DlRF developed at 18oC causes reduction in Delta
activity. Chmp1 over-expression phenotypes resemble reduction of Delta phenotypes
(34).
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Figure 13. Over-expression of Chmp1 in the wing.
A. MS1096-Gal4; UAS-Chmp1 5491-2-2M male wing developed at 25oC. B. MS1096Gal4; UAS-Chmp1 5491-2-2M male wing developed at 28oC. C. MS1096-Gal4; UASChmp1 5491-2-2M male wing developed at 30oC. D. MS1096-Gal4; UAS-Chmp1 54912-4M male wing developed at 25oC. E. MS1096-Gal4; UAS-Chmp1 5491-2-4M male
wing developed at 28oC. F. MS1096-Gal4; UAS-Chmp1 5491-2-4M male wing
developed at 30oC.
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Figure 14. Over-expression of tagged Chmp1 in the wing.
A. MS1096-Gal4; UAS-Chmp1 5491-1-6M male wing developed at 25oC. B. MS1096Gal4; UAS-Chmp1 5491-1-6M male wing developed at 28oC. C. MS1096-Gal4; UASChmp1 5491-1-6M male wing developed at 30oC. D. MS1096-Gal4; UAS-Chmp1 54911-3M male wing developed at 25oC. E. MS1096-Gal4; UAS-Chmp1 5491-1-3M male
wing developed at 28oC. F. MS1096-Gal4; UAS-Chmp1 5491-1-3M male wing
developed at 30oC.
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Section 5: Discussion
To date, studies with Chmp1 and its homologues show that mis-expression of
Chmp1 causes overgrowth (22, 33). Chmp1 knockdown in the Drosophila wing results
in oversized wing veins. This result suggests that Chmp1 is involved in regulation of
growth in Drosophila. This is consistent with previous research and suggests that
Drosophila is a good model for studying Chmp1 function. The establishment of wing
veins in the Drosophila wing is dependent upon EGF and Notch-Delta signaling. Since
mis-expression of Chmp1 results in vein phenotypes, Chmp1 may be regulating these
pathways.
As these pathways are quite dependent upon each other in the formation of wing
veins, it is possible that Chmp1 is involved in the regulation of only one of the pathways.
Chmp1 knockdown phenotypes suggest that Chmp1 is regulating EGF signaling, while
over-expression phenotypes suggest that it is regulating Notch-Delta signaling. It is not
clear yet exactly how Chmp1 is acting on these two pathways. One possibility is a simple
matter of ESCRT function. It is probable that Chmp1 over-expression and knockdown
would have an effect on ESCRT, as it is a functioning member of the protein complex.
Significantly, both the EGF and Notch pathways are reported in the literature to be
regulated by ESCRT machinery. Studies with EGF signaling and ESCRT have shown
that deletion of ESCRT-III component Vps24 (also known as Chmp3) results in
persistent EGF signaling (73). This information is consistent with our results that a defect
in ESCRT-III component Chmp1 results in over-active EGF signaling as well. In the
Notch-Delta pathway, Notch is continuously being internalized and either recycled or
degraded. This seems dependent upon ESCRT, as mutations in ESCRT significantly
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affect Notch activity (74, 75). Studies have shown that tumor suppressor and ESCRT-II
component Vps25, regulates Notch activity. When Vps25 is deleted, Notch is improperly
degraded, which leads to over-proliferation (17). The activity of Vps25 may be similar to
Chmp1, as its absence leads to loss of growth control, possibly through the regulation of
Notch or EGF. Additionally, it seems that in order for Delta to be active it is
monoubiquitinated by ubiquitin ligases, which have been shown to physically interact
with Delta and promote ubiquitination and internalization (76, 77, 78). Although the
ESCRT machinery usually mediates degradation and recycling of monoubiquitinated
transmembrane receptors, it seems that in this case, it works on a transmembrane ligand
(75). This could be consistent with our over-expression results, if heightened Chmp1
activity lead to increased ESCRT III activity and therefore increased Delta degradation,
the result may be a phenotype similar to reduced Delta activity. It has already been
discussed in the literature that ESCRT machinery plays a very important role in the
recycling and degradation of activated receptor proteins. The implications of this
regulation are very important. Without proper ESCRT, cell signaling can be thoroughly
disrupted, and may lead to considerable problems in the cell such as over-proliferation.
Chmp1 has been linked to pancreatic cancer in humans. Pancreatic tumors have
lowered Chmp1expression compared to normal pancreatic cells (22). Another
characteristic of many pancreatic tumors, which may be a result of Ras mutations, is an
over-active Epidermal Growth Factor (EGF) pathway (24). Both the EGF receptor and its
ligands have increased expression and activity in pancreatic tumors (79). Our results
suggest that Chmp1 negatively regulates EGF signaling, which would be consistent with
these previous findings, as lowered Chmp1 expression would enhance EGF signaling.
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Although cancers, pancreatic cancer included, usually have a whole hoard of problems,
there may be a very important link between EGF signaling and Chmp1 expression.

Section 6: Future Studies
We are pretty sure the phenotypes obtained are due to Chmp1 knockdown, as two
different RNAi lines exhibit similar results. It would be nice to quantify the level of
Chmp1 knockdown, which may be easy to do with a western blot and a good antibody.
The UAS-Chmp1 lines need to be balanced. In doing this, we will find out into
which chromosome the Chmp1 transgene was inserted. Then, to help characterize the
function of Chmp1, we can obtain more Chmp1 over-expression phenotypes in the
Drosophila wing. We will also want to over-express Chmp1 while knocking down or
over-expressing EGF pathway components and possibly Notch pathway components.
Additionally, at some point we need to check that Chmp1 is in fact being over-expressed,
and possibly quantify the level of over-expression. This may be easy to do with a western
blot and a good antibody, or mRNA assays.
The EGF pathway is quite active in the Drosophila eye. Over-expression and
knockdown of Chmp1 in the eye will be performed, to investigate whether Chmp1
functions in the same pathways in the wing as the eye. This will require uncomplicated
crosses. We have recently obtained a protocol for eye fixation and sectioning that will
allow for visualization of ommatidial cells. SEM images of the full eye may be useful as
well.
As the pUASHM vector has tagged Chmp1 with HM, we should now be able
visualize the localization of Chmp1 protein within the cells. Wing disc staining and
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imaging using confocal microscopy could be useful and informative. The salivary glands
of the Drosophila third instar larvae have polytene chromosomes, which can be easily
stained and visualized under a light microscope. As previous studies have shown Chmp1
to localize with condensed chromatin, we can use these Chmp1 HM-tagged lines
investigate whether the same is true in Drosophila.
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Bridge to Chapter 2
We have shown through Chmp1 knockdown and over-expression that Chmp1
may regulate the Notch-Delta and EGF signaling pathways. The Notch-Delta and EGF
pathways are fairly dependent on each other, and actively work together to promote
proper wing vein formation in the Drosophila wing. However, both Chmp1 knockdown
and over-expression results in another phenotype that suggests that Chmp1 regulates a
different and seemingly separate pathway as well, which is known as the Frizzled Planar
Cell Polarity pathway. The Frizzled Planar Cell Polarity pathway is responsible for
establishing proper planar cell polarity (PCP) in the Drosophila cuticle. We explored the
effect of Chmp1 on PCP, and found that Chmp1 may regulate this pathway through a
PCP protein called Strabismus.
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Chapter 2 – Chmp1 and Planar Cell Polarity

Section 1: Introduction
Cell polarity is caused by an asymmetrical distribution of molecules in a cell. The
establishment of cell polarity in organisms is extremely important for cell diversity and
tissue specialization. During development almost all cells become polarized in some way,
and in many cases, the polarity of the cells must be correctly coordinated with the
polarity of the tissue (80, 81). One quite common example of this is planar cell polarity
(PCP), in which epithelial cells become polarized in a plane of epithelium not only on the
apical-basal axis, but also within the plane of cells (82). This cell polarity is important for
the proper function of many tissues, from the sensory hair cells in the vertebrate inner ear
to hair and feather arrangement in animals (82). PCP has been studied extensively in the
Drosophila cuticle and many polarity proteins have been identified that are required for
the process (83). One of the key components for the establishment of cell polarity is a
conserved pathway called the Frizzled Planar Cell Polarity pathway (Figure 15) (84).
Some of the significant members of this pathway include Frizzled (Fz),
Disheveled (Dsh), Prickle (Pk), Van Gogh (Vang, also known as Strabismus [Stbm]),
Diego (Dgo), and Starry night (Stan, also known as Flamingo [Fmi]). Fz is a seven-pass
transmembrane receptor which localizes at the distal end of the developing wing cell (85,
86), Dsh is a cytoplasmic protein and colocalizes with Fz (87, 88), Vang/Stbm is a four
pass transmembrane protein and is found at the proximal end of the developing wing cell
(89, 90), Stan/Fmi is a seven-pass membrane protein with cadherin domains and localizes
both proximally and distally (88, 91, 92), Pk is a cytoplasmic protein which accumulates
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at the proximal edge (94, 95), and Dgo is a cytoplasmic protein which accumulates at the
distal and proximal edges (95). The asymmetric distribution of these proteins is important
for intracellular and extracellular signaling, and proper PCP establishment. Failure to
appropriately localize of all six of these proteins results in a disruption of PCP.

Figure 15. Frizzled signaling pathway (96).
In Drosophila melanogaster, PCP is required for proper organization of cuticular
structures in the adult organism, but has been best characterized in the wing, sensory
bristles and eye. In the wing, it is required for correct orientation and number of wing
hairs produced by the wing cells and mutations in any one of the PCP proteins disrupt the
wing hair polarity. Depending on the mutated protein, a wing hair may be produced in a
different area of the cell, pointing a different direction, or multiple hairs may be produced
per cell (83).
Although the Fz PCP pathway was initially characterized in epithelial structures
in Drosophila, it seems to be a conserved pathway in vertebrates and is required for many
diverse processes. Vertebrate PCP was first discovered to be required for convergent
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extension movements in during neurulation in Xenopus and zebrafish embryos (97, 98,
99). There is now evidence that it is also involved in the process of neural tube closure
(99, 100), cardiovascular development (101) and establishing the precisely aligned
orientations of sensory hair cells in vertebrate ears (100, 102).
Strabismus is a transmembrane protein that has been shown to physically interact
with Fz-PCP pathway proteins Pk, Dgo, and Dsh (90, 103, 104). Recent studies in
zebrafish show that the PCP protein, Stbm, can physically interact with Chmp1A in a
yeast two-hybrid screen as well as in a co-immunoprecipitation assay (33). A study done
by Dr. Maiyon Park at Marshall University School of Medicine showed that loss of Stbm
activity in zebrafish embryos causes faulty convergent extension 12. The resulting embryo
has a short and wide body, opposed to the normal long and narrow body. The same study
found that loss of Chmp1A activity during zebrafish embryogenesis results in a
convergent extension phenotype very similar to loss of Stbm, suggesting a physical
Chmp1A-Stbm interaction that may regulate cell movement.

Section 2. Objective and Hypothesis
Section 2.1: Objective
There were two objectives of this study. The first objective was to determine if
Chmp1 regulates planar cell polarity (PCP) in Drosophila by observing the effect of
knockdown and over-expression. The second objective was to determine if Chmp1
interacts with PCP protein, Strabismus, in Drosophila.

12

Convergent extension is a process during embryogenesis where cells come together
(converge) and lengthen (extend) the body. It only involves the movement of cells, not
change in cell shape or cell division.
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Section 2.2: Hypothesis
We hypothesize that Chmp1 in Drosophila regulates PCP through an interaction
with PCP protein, Strabismus, like it does in zebrafish.

Section 3: Materials and Methods
Table 5. Genotypes of fly lines used
Name

Genotype

Oregon R (wild-type)

Oregon R-C

Chmp1IR/Cy

w1118; P{GD11219}v21788/CyO

MS1096-Gal4

w1118 P{w+mW.hs=GawB}BxMS1096

VangTBS42

b pr cn TBS42/CyO

en-gal4

P {en2.4-GAL4}e16E

Section 4: Results
As previous studies in zebrafish have shown a possible Chmp1-Stbm interaction,
we wanted to see if the same was true for Drosophila. As we already have fly lines
heterozygously mutant for Stbm, and the Chmp1IR line, this was rather simple.
In order to test for a Chmp1-Stbm interaction, about 10 Chmp1IR/Cy male flies
were crossed to 10 MS1096-Gal4; Cy/Sco female virgins. The parent generation was
moved to a new vial containing fresh food every 2-3 days. From that cross, 10 first
generation virgin females that were MS1096-Gal4; Chmp1IR/ Sco were then crossed to
10 VangTBS42/Cy males. The parent flies for this cross were moved to a new vial
containing fresh food every 2-3 days. The flies obtained from this cross were cultured
during their development at 25o, 28o and 30o. The flies that were used were those
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cultured at 28oC, as they produced the best phenotypes. Culturing at 25oC produces a
rather weak phenotype, while culturing at 30oC, which is the optimal temperature for the
UAS-Gal4 system, produces very strong Chmp1 phenotypes, resulting in wings in which
vein and intervein tissues are indistinguishable and rendering PCP phenotypic studies
rather useless. The wings on the right side of the flies were dissected off and mounted
dorsally on a microscope slide in GMM.
Flies heterozygous for stbm (VangTBS42) have a weak dominant phenotype in the
proximal part of the wing, but mostly exhibit a wild-type wing phenotype (Figure 16A).
There was no vein overgrowth, and hardly any PCP phenotype was observed. This
indicates that low Stbm activity is sufficient for proper PCP. Ubiquitous Chmp1
knockdown in the wing results in wing vein overgrowth (Figure 16B), but no PCP
phenotypes. This result alone would suggest that PCP is unaffected by Chmp1. However,
knocking down Chmp1 in wings heterozygous for stbm results in overgrown wing veins
as well as a PCP phenotype, which includes multiple hairs produced per cell and a change
in hair polarity (Figure 16C). This result does suggest that Chmp1 and Stbm are
somehow interacting, as PCP is only disrupted when both of the proteins are less active,
and PCP is executed properly when Chmp1 and Stbm levels are normal. The PCP
phenotype observed here is similar to phenotypes observed in wings homozygously
mutant for stbm, as well as other PCP mutant wings, including Fz (105). Interestingly, the
most noticeable PCP phenotype in these wings was seen in the wing hairs surrounding
the wing veins. Usually, wing hairs point toward high Stbm activity (Figure 16C),
suggesting that the wing veins have lower Stbm than the intervein tissue, but also that
reduced activity of Stbm is associated with reduced activity of Chmp1.
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To test that these results were consequential of and specific to a Chmp1-Stbm
interaction, Chmp1 was also knocked down with other members of the PCP pathway.
When Chmp1 is knocked down along with reduced activity of Fz (MS1096-Gal4; UASChmp1IR; fzP21/+) or Pk (MS1096-Gal4; UAS-Chmp1IR/ pkpk-sple14), no PCP phenotypes
are observed. This suggests that the PCP phenotype observed is indeed due to a Chmp1Stbm interaction, rather than a Chmp1 interaction with other PCP proteins.
We also looked at Chmp1 knockdown alone in the wing, both ubiquitously and in
the posterior half of the wing. To look at ubiquitous Chmp1 knockdown, Chmp1IR/Cy
females were crossed to MS1096-Gal4; Cy/Sco males. In order to look at Chmp1
knockdown in the posterior half of the wing, Chmp1IR/Cy virgin females were crossed to
en-Gal4 males. The parent generation of each cross was moved to a new vial with fresh
fly food every two to three days, and the first generation was cultured at 25 oC, 28oC, and
30oC. The wings used for this study were those developed at 28 oC. The wings were
dissected off of the flies and mounted dorsally on a glass slide in GMM. As we saw
previously, when Chmp1 was knocked down ubiquitously in the dorsal wing, the result
was vein overgrowth and no PCP phenotypes were observed (Figure 16B, D). However,
when Chmp1 is knocked down in only the posterior half of the wing, we do see PCP
phenotypes, such as doubled hairs and a change in hair polarity, at the boundary of
Chmp1 knockdown and normal levels Chmp1 expression (Figure 16E). This suggests that
in order for Chmp1 alone to have an effect on PCP, there must be a gradient of Chmp1
activity.
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Figure 16. Chmp1 and Stbm.
A. A wing heterozygous for Stbm (stbmVangTBS42) has an apparent wild-type wing B.
Chmp1 knockdown (MS1096-Gal4; UAS-ChmpIR) results in overgrown wing veins C. A
wing heterozygous for Stbm, as well as having Chmp1 knockdown (MS1096-Gal4; UASChmp1IR/stbmVangTBS42) results in overgrown wing veins, but also a PCP phenotype as
hair polarity is abnormal D. Wild-type wing (Oregon R) E. Knockdown of Chmp1 in the
posterior half of the wing (en-Gal4; UAS-Chmp1IR) results in overgrown wing veins in
the posterior half of the wing, but also PCP phenotypes such as doubled hairs (circled in
red) and abnormal hair polarity at the boundary of Chmp1 knockdown.

Unexpectedly, PCP effects were also observed in Chmp1 over-expression wings.
The over-expression lines that were created, when crossed to MS1096-Gal4, should overexpress Chmp1 ubiquitously in the wing. Nine out of the ten untagged over-expression
lines resulted in phenotypes indicative of faulty PCP (Figure 17). The PCP effects are not
as severe as those observed in regional Chmp1 knockdown.
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Figure 17. Untagged Chmp1 over-expression in the Drosophila wing resulted in PCP
effects.
Doubled hairs are indicated in the red circles. All wings were from male adults developed
at 28oC. All images were taken between the L3 and L5 veins, near the PCV and ACV
(usually missing in these wings). A.) MS1096-Gal4; UAS-Chmp1 5491-2-1M B.)
MS1096-Gal4; UAS-Chmp1 5491-2-2M C.) MS1096-Gal4; UAS-Chmp1 5491-2-3M D.)
MS1096-Gal4; UAS-Chmp1 5491-2-4M E.) MS1096-Gal4; UAS-Chmp1 5491-2-5M F.)
MS1096-Gal4; UAS-Chmp1 5491-2-6M G.) MS1096-Gal4; UAS-Chmp1 5491-2-7M
H.) MS1096-Gal4; UAS-Chmp1 5491-2-8M I.) MS1096-Gal4; UAS-Chmp1 5491-2-9M
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Section 5: Discussion
The results of this study suggest that there is indeed an interaction between
Chmp1 and Stbm in Drosophila, and that this interaction is important for the
establishment of proper PCP. When Chmp1 and Stbm interact in the correct fashion,
proper PCP is established. However, when the interaction between Chmp1 and Stbm is
disrupted, PCP is disrupted as well. It is unknown how these proteins are interacting,
though from previous studies, it seems that the interaction is not permanent, but is short
lived (33).
Studies in zebrafish suggest that Chmp1 regulates PCP through an interaction
with Stbm (33). Phenotypes obtained from Chmp1 knockdown in zebrafish resembled
stbm mutants, and the same seems true for Drosophila. It is very nice that we see the
same result in Drosophila as was observed in zebrafish. This suggests that Chmp1
function is conserved between zebrafish and Drosophila, and it is possible that is
conserved between other organisms as well.
Stbm is a transmembrane protein. It has recently been described as a
transmembrane receptor for Fz extracellular domain (106). It has not been shown that
Stbm is regulated by ESCRT machinery, nor have any results been published regarding
regulation of Stbm by ubiquitination. Nevertheless, its receptor capabilities make it a
potential ESCRT target. Other than being a member of ESCRT, Chmp1 has also been
implicated in gene silencing. Chmp1 is normally associated with condensed chromatin
and recruitment of gene silencing proteins, and it is possible that this action of Chmp1 is
important in the regulation of Stbm, or genes that may regulate Stbm.
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An interesting result was the way Chmp1 seems to affect hair polarity. When
Chmp1 was knocked down in a background of Stbm, the strongest effect on hair polarity
was seen at the wing veins. Specifically, hairs pointed away from the wing vein.
Typically in the wing, hairs point toward high Stbm activity. This would suggest that
there is lower Stbm in the wing vein. However, the driver (MS1096-Gal4) that we used
should drive Chmp1-IR ubiquitously in the wing. If Chmp1 does regulate PCP through
Stbm, it is strange that ubiquitous Chmp1 knockdown would result in localized reduction
of Stbm. One possible explanation for this is that wing vein tissue and intervein tissue
have different requirements for Chmp1, and therefore each tissue is differentially affected
by Chmp1 knockdown.
Chmp1 has been linked to pancreatic cancer. Previous studies, as well as our
studies, suggest that Chmp1 is involved in the regulation of growth. In Drosophila,
Chmp1 knockdown and over-expression result in what seem to be two differential
phenotypes: 1) misregulation of growth and 2) planar cell polarity effects. These
phenotypes may not be as far separated as we originally thought. There are some recent
reports linking PCP to cancer. One study found that in loss of VANGL2, human
homologue of Strabismus, promotes migration and invasion in human cancer cells (108).
Additionally, aberrant activation of the PCP signaling pathway in human cancer cells can
lead to more malignant phenotypes (109). If PCP is regulated by Chmp1, it is possible
that Chmp1 misregulation could lead to cancer-related phenotypes such as overproliferation or migration, as well as PCP phenotypes, resultant of faulty Fz-PCP
signaling.
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Section 6: Future Studies
Although in it was found that Chmp1 and Stbm interact in zebrafish, it might be a
good idea to do an assay to make sure that the same is true in Drosophila. Our results do
suggest the Chmp1-Stbm interaction, but we still want to be positive. This could be done
using a yeast two-hybrid assay. Another method, and maybe a more informative one,
would be a co-immunoprecipitation.
Now that we have the Chmp1 over-expression lines available we can look at
Chmp1 over-expression along with reduced activity of Stbm. This simple cross could
provide more information as to how Chmp1 may be involved with PCP. Additionally,
one of our over-expression lines has a tagged Chmp1 protein. With some good
antibodies, we could look at Chmp1 localization, along with Stbm localization, for
further support of a Chmp1-Stbm interaction.
We looked at Chmp1 knockdown along with reduced activity of Fz and Pk, but it
would probably be a good idea to look at Chmp1 knockdown along with reduced activity
of Fmi, since it is a transmembrane protein.
It may be interesting to look at Chmp1 and Stbm in the eye of the fly. This would
be very simple, as we already have some fly lines that drive Gal4 in the eye. The eye is a
very regular structure, and the establishment of cell polarity by PCP is extremely
important. This and the regular structure of the eye make the eye good place to study PCP
in the fly, as small problems become very apparent.
It would be very nice find out whether Chmp1 regulates Stbm by the ESCRT
machinery. We could try to find out whether Stbm is ubiquitinated at the membrane. If it
is, that small bit of evidence would be very suggestive of ESCRT regulation.
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Final Discussion
Our results suggest that Chmp1 regulates three different pathways in the
Drosophila wing: the Epidermal Growth Factor Pathway, Notch-Delta signaling, and the
Frizzled Planar Cell Polarity pathway. Our studies of Chmp1 knockdown and EGF
regulators in the wing indicate that Chmp1 negatively regulates the EGF pathway during
wing vein development in Drosophila. When we over-express Chmp1 in the wing, we see
what appears to be faulty Notch-Delta signaling, which is apparent by the “delta” wing
vein phenotype. Both the EGF pathway and Notch-Delta signaling are very important for
wing vein development and actively interact to promote proper wing vein size. At this
point, it is unclear whether Chmp1 regulates one or both of these signaling pathways. It is
also unclear at what level Chmp1 regulation comes into play. Chmp1 has two major
functions in the cell: it mediates the degradation of activated receptor proteins through
ESCRT, but it also is involved in gene silencing in the nucleus. It is possible that
regulation is at the level of transcription. However, it is most likely that Chmp1 regulates
these pathways through its ESCRT function. The EGF receptor, the Notch receptor, and
the Delta ligand are all probably regulated by ESCRT machinery. Thus, if mis-regulation
of Chmp1 affects ESCRT function, these signaling pathways would be affected.
Our studies also suggest that Chmp1 regulates Fz-PCP signaling by an interaction
with PCP protein, Strabismus. Strabismus is a transmembrane receptor protein, and
therefore it is possible that it is regulated by ESCRT machinery as well. Our studies so
far make it seem as though Chmp1 regulation of EGF/Notch-Delta signaling and PCP is
separate, since Chmp1 knockdown and over-expression seemed to result in two different
phenotypes. However, it would be interesting if there was more of a connection than
55

between these pathways than is traditionally thought. In the Drosophila wing, wing veins
are formed by the EGF pathway. When EGF activators are absent, no wing vein forms,
which suggests that EGF signaling is absolutely necessary for wing vein formation.
Interestingly, hair polarity in the wing, which is directed by the Fz-PCP pathway, is often
affected near the wing veins. A possibility for this wing vein effect on hair polarity is that
EGF signaling affects PCP signaling. When we knocked down Chmp1while reducing
Stbm activity, the strongest phenotype was observed at the wing vein, where the hair
polarity was severely altered. This was an unexpected and rather confusing result. It is
possible that the change in hair polarity is a result of an interaction of Fz-PCP and EGF
signaling. There have been some reports of the need for cooperative EGF and Fz-PCP
signaling to establish cell fate and planar cell polarity (110). It is possible that these
pathways are interconnected and that each can influence the activity of the other.
Ultimately, there is still much that is unclear, and further investigation is needed to
determine exactly how Chmp1 may regulate these pathways.
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Figure 18. Inserting Chmp1 into pUAST
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Figure 19. Inserting Chmp1 into pUASHM
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Source: Berkeley Drosophila Genome Project

Figure 20. pOT2 vector
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Source: Addgene

Figure 21. pUAST vector
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Figure 22. pUASHM vector
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Source: Stratagene
Figure 23. pBluescript vector
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